Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa

Autor: M Viveros-Rogel, D Lewinsohn, G Sherman, M Nielsen, EB Wong, S Dinapoli, M Mohns, M Lauck, K Elkington, C Vega, J Sierra-Madero, M Mitha, G Haret-Richter, K Crosno, N Klatt, A Burgener, T Friedrich, P Baijnath, L Soto-Ramirez, D Ma, EJ Abrams, K Doerholt, T He, A Pasternak, J Manuzak, A Ericsen, J Mutschler, A Judd, B Burwitz, U Lalloo, C Miller, F Karim, B Xulu, E Brocca-Cofano, M Suleman, MP Fox, C Apetrei, T Hensley-Mcbain, C Xu, A Tello-Mercado, AK Shalek, J Weinfurter, Jason M. Brenchley, R Tracy, C Wilson, C Dolezal, R Cheu, J Bor, E Chappell, CS Leu, A Cardenas-Ochoa, L Leon-Fuentes, CA Mellins, D Franck, T Ndung'u, M Maskew, J Prins, S Carmona, P Maharaj, C Costiniuk, M Vergara-Mendoza, A Bucek, R Wiseman, L Galli, Jonah B. Sacha, Z Mhlane, S Perez-Patrigeon, G Lehrer-Brey, P Warne, M Reynolds, I Pandrea, E Peterson, J Stock, W MacLeod, J Greene, Moodley, S Prakadan, B Berkhout, A Landay, M Rodriguez-Castañón, E Lee, B Policicchio, David H. O’Connor, A Zevin

Publikováno v: Journal of the International AIDS Society. 19:21264

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd22b24ddf60b48e6b09349cff51d3af
https://doi.org/10.7448/ias.19.6.21264

Implications of subclinical tuberculosis for vaccine trial design and global effect.

Autor: Churchyard GJ; Aurum Institute NPC, Houghton, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA; School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Electronic address: gchurchyard@auruminstitute.org., Houben RMGJ; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Fielding K; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Fiore-Gartland AL; University of Washington, Seattle, WA, USA., Esmail H; MRC Clinical Trials Unit, University College London, London, UK; WHO Collaborating Centre for TB Research and Innovation, Institute for Global Health, University College London, London, UK., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Rangaka MX; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Behr M; McGill International TB Centre, McGill University, Montreal, QC, Canada., Garcia-Basteiro AL; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain., Wong EB; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa; Division of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Hatherill M; South African Tuberculosis Vaccine Initiative, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mave V; Byramjee-Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India., Dagnew AF; Gates Medical Research Institute, Cambridge, MA, USA., Schmidt AC; Gates Medical Research Institute, Cambridge, MA, USA., Hanekom WA; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Cobelens F; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100895. Date of Electronic Publication: 2024 Jul 01.

LNK/ SH2B3 as a novel driver in juvenile myelomonocytic leukemia.

Autor: Wintering A; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Hecht A; Department of Hematology/Oncology, Klinikum Rechts der Isar, Technische Universität München, München., Meyer J; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Wong EB; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Hübner J; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Abelson S; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Feldman K; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158., Kennedy VE; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94158., Peretz CAC; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158., French DL; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104., Maguire JA; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104., Jobaliya C; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104., Vasquez MR; Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada., Desai S; Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada., Dulman R; Pediatric Hematology and Oncology, Pediatric Specialists of Virginia, Fairfax, VA 22031., Nemecek E; OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239., Haines H; Children's of Alabama, University of Alabama Hospital, Birmingham, AL 35233., Hammad M; National Cancer Institute, Cairo University, Cairo, Egypt., El Haddad A; National Cancer Institute, Cairo University, Cairo, Egypt., Kogan SC; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94158., Abdullaev Z; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814., Chehab FF; Institute for Human Genetics, University of California San Francisco, San Francisco, CA 94143., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia; Philadelphia, PA 19104, USA; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine; Philadelphia, PA 19104., Smith CC; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94158, USA; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, 98105. mignon.loh@seattlechildrens.org., Stieglitz E; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158, USA; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158. elliot.stieglitz@ucsf.edu.

Publikováno v: Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2533-2541. Date of Electronic Publication: 2024 Aug 01.

Simultaneous alleviation of verification and reference standard biases in a community-based tuberculosis screening study using Bayesian latent class analysis.

Autor: Keter AK; Institute of Tropical Medicine, Antwerp, Belgium.; Center for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.; Ghent University, Ghent, Belgium., Vanobberghen F; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Lynen L; Institute of Tropical Medicine, Antwerp, Belgium., Van Heerden A; Center for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.; Faculty of Health Sciences, Department of Paediatrics, SAMRC/WITS Developmental Pathways for Health Research Unit, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, Gauteng, South Africa., Fehr J; Africa Health Research Institute, Durban, South Africa.; Hasso-Plattner-Institute for Digital Engineering, Potsdam, Germany., Olivier S; Africa Health Research Institute, Durban, South Africa., Wong EB; Africa Health Research Institute, Durban, South Africa.; University of Alabama at Birmingham, Birmingham, Alabama, United States of America., Glass TR; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Reither K; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Goetghebeur E; Ghent University, Ghent, Belgium., Jacobs BKM; Institute of Tropical Medicine, Antwerp, Belgium.

Publikováno v: PloS one [PLoS One] 2024 Jun 10; Vol. 19 (6), pp. e0305126. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).

Identification and molecular characterization of Mycobacterium bovis DNA in GeneXpert® MTB/RIF ultra-positive, culture-negative sputum from a rural community in South Africa.

Autor: Goosen WJ; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa., Moodley S; Africa Health Research Institute, KwaZulu-Natal, South Africa., Ghielmetti G; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa.; Section of Veterinary Bacteriology, Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 270, 8057 Zurich, Switzerland., Moosa Y; Africa Health Research Institute, KwaZulu-Natal, South Africa., Zulu T; Africa Health Research Institute, KwaZulu-Natal, South Africa., Smit T; Africa Health Research Institute, KwaZulu-Natal, South Africa., Kleynhans L; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa.; Mater Research Institute - The University of Queensland, Translational Research Institute, Brisbane, QLD 4102, Australia., Kerr TJ; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa., Streicher EM; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa., Hanekom WA; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Division of Infection and Immunity, University College London, London, UK., Warren RM; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa., Wong EB; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Division of Infectious Diseases, Department of Medicine, Heersink School of Medicine, University of Alabama Birmingham, Birmingham, AL, USA., Miller MA; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa.

Publikováno v: One health (Amsterdam, Netherlands) [One Health] 2024 Mar 03; Vol. 18, pp. 100702. Date of Electronic Publication: 2024 Mar 03 (Print Publication: 2024).